var data={"title":"Gonococcal infection in the newborn","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Gonococcal infection in the newborn</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/contributors\" class=\"contributor contributor_credentials\">Michael E Speer, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/contributors\" class=\"contributor contributor_credentials\">Leonard E Weisman, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/contributors\" class=\"contributor contributor_credentials\">Sheldon L Kaplan, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/contributors\" class=\"contributor contributor_credentials\">Carrie Armsby, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 27, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Perinatal acquisition of sexually transmitted diseases (STDs) can have serious consequences for the newborn. Ophthalmia neonatorum (newborn conjunctivitis) was caused principally by Neisseria gonorrhoeae at one time in the United States and was the most common cause of blindness. Although this newborn infection has decreased in frequency throughout the world, the consequences of untreated disease remain grave. Gonococcal infection in the newborn is reviewed here. Neonatal infection with other sexually transmitted organisms is discussed separately:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=chlamydia-trachomatis-infections-in-the-newborn\" class=\"medical medical_review\">&quot;Chlamydia trachomatis infections in the newborn&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=congenital-syphilis-evaluation-management-and-prevention\" class=\"medical medical_review\">&quot;Congenital syphilis: Evaluation, management, and prevention&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention\" class=\"medical medical_review\">&quot;Neonatal herpes simplex virus infection: Management and prevention&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=hepatitis-viruses-and-the-newborn-clinical-manifestations-and-treatment\" class=\"medical medical_review\">&quot;Hepatitis viruses and the newborn: Clinical manifestations and treatment&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diagnostic-testing-for-hiv-infection-in-infants-and-children-younger-than-18-months\" class=\"medical medical_review\">&quot;Diagnostic testing for HIV infection in infants and children younger than 18 months&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incidence of neonatal gonococcal infection relates to the prevalence of infection among women of childbearing age, which varies somewhat worldwide. In resource-rich regions, the prevalence of gonococcal infection among pregnant women is &lt;1 percent; the prevalence in resource-limited settings is considerably higher. (See <a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-neisseria-gonorrhoeae-infection#H853159200\" class=\"medical medical_review\">&quot;Epidemiology and pathogenesis of Neisseria gonorrhoeae infection&quot;, section on 'Global incidence'</a>.)</p><p>In pregnant women, coinfection with <em>Chlamydia trachomatis</em> is common and HIV transmission is heightened in the presence of gonorrhea [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/1-3\" class=\"abstract_t\">1-3</a>]. (See <a href=\"topic.htm?path=epidemiology-of-chlamydia-trachomatis-infections\" class=\"medical medical_review\">&quot;Epidemiology of Chlamydia trachomatis infections&quot;</a> and <a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-neisseria-gonorrhoeae-infection#H853159690\" class=\"medical medical_review\">&quot;Epidemiology and pathogenesis of Neisseria gonorrhoeae infection&quot;, section on 'Association with HIV'</a>.)</p><p>In the newborn, the eye is the most frequent site of gonococcal infection [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/4\" class=\"abstract_t\">4</a>]. Ophthalmia neonatorum (newborn conjunctivitis) was caused principally by <em>Neisseria gonorrhoeae</em> at one time in the United States and was the most common cause of blindness. However, in the modern era, gonococcal ophthalmia neonatorum is rare in developed countries due in large part to routine prophylaxis. (See <a href=\"#H13\" class=\"local\">'Neonatal prophylaxis'</a> below.)</p><p>In an Argentinian study of 332 neonates with conjunctivitis, the most common causes were <em>Haemophilus influenzae </em>(17 percent), <em>Streptococcus pneumoniae</em> (12 percent), <em>Staphylococcus aureus</em> (9 percent), and <em>C. trachomatis</em> (8 percent); no cases of gonococcal infection were identified [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/5\" class=\"abstract_t\">5</a>]. Half of the cases had no pathogen detected. In another series of 81 infants with ophthalmia neonatorum treated in the United Arab Emirates, <em>S. aureus</em> was the most common pathogen and <em>N. gonorrhoeae</em> and <em>C. trachomatis</em> were responsible for &lt;5 percent of cases [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/6\" class=\"abstract_t\">6</a>]. In a series of 163 cases of neonatal conjunctivitis from India, <em>N. gonorrhoeae</em> was recovered in only a single patient; staphylococci were again the most frequent isolates [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/7\" class=\"abstract_t\">7</a>].</p><p>The epidemiology of <em>N. gonorrheae</em> infection is discussed in greater detail separately. (See <a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-neisseria-gonorrhoeae-infection#H2\" class=\"medical medical_review\">&quot;Epidemiology and pathogenesis of Neisseria gonorrhoeae infection&quot;, section on 'Epidemiology'</a>.)</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>N. gonorrhoeae</em> are gram-negative diplococci. The structure of the organism resembles other gram-negative bacteria with a cell envelope composed of an inner cytoplasmic membrane, a middle layer of peptidoglycan, and an outer membrane [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/8\" class=\"abstract_t\">8</a>]. The outer membrane contains lipooligosaccharide, phospholipid, and a variety of proteins. Porin (formerly called protein I) accounts for 60 percent of the outer membrane protein content, allows for the passage of solutes, and forms the basis of a classification system [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/9\" class=\"abstract_t\">9</a>]. Por 1A and Por 1B are the two major antigenic classes, and both are comprised of serovars upon which the serotyping system for gonococci is based [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/10\" class=\"abstract_t\">10</a>]. Por 1A strains tend to be resistant to the bactericidal effect of serum and preferentially cause bacteremia [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/9,10\" class=\"abstract_t\">9,10</a>].</p><p>Infection with <em>N. gonorrhoeae</em> encompasses four specific stages [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/11-13\" class=\"abstract_t\">11-13</a>] (see <a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-neisseria-gonorrhoeae-infection\" class=\"medical medical_review\">&quot;Epidemiology and pathogenesis of Neisseria gonorrhoeae infection&quot;</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Attachment to the mucosal cell surface</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Local penetration or invasion</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Local proliferation</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Local inflammatory response or dissemination</p><p/><p>Initial attachment of gonococci to the surface of columnar epithelial cells is mediated by type IV pili, which are filamentous outer membrane appendages composed of multiple subunits, the most important of which is pilin or PilE, which forms the pilus fiber [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/14\" class=\"abstract_t\">14</a>]. Other outer membrane structures involved in gonococci attachment include PilC proteins and Opa (opacity related proteins, formerly labeled protein II).</p><p>Local invasion initially involves multiple adhesins that interact with a variety of host receptors. After attaching to mucosal cells, gonococci become engulfed in a process known as parasite-directed endocytosis. Gonococci are able to undergo intracellular replication, both within phagocytic vacuoles and within columnar epithelial cells. The organism has developed complex strategies to avoid host defense mechanisms, allowing dissemination to occur. Mucosal surfaces and subepithelial tissues are the primary sites of infection [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/8\" class=\"abstract_t\">8</a>]. However, the organism may extend through lymphatics or, less often, the bloodstream, and cause systemic disease.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">PERINATAL TRANSMISSION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Newborns typically acquire gonococcal infection during delivery. Perinatal transmission occurs in 30 to 40 percent of cases of maternal cervical infection in the United States [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/15\" class=\"abstract_t\">15</a>]. Intrauterine infection also can occur after rupture of the membranes.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Association with prematurity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Untreated maternal gonococcal disease appears to increase the risk of preterm delivery [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/16\" class=\"abstract_t\">16</a>]. Reported rates of prematurity range from 13 to 67 percent, although most studies include relatively few patients and provide little information on associated conditions or concurrent infections [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/17-22\" class=\"abstract_t\">17-22</a>].</p><p>In one study, the rate of preterm delivery was 22 percent of 222 patients [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/17\" class=\"abstract_t\">17</a>]. In another series from South Africa, untreated gonococcal infection was associated with an attributable risk of prematurity of 72 percent, although the number of such infected patients was small [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/19\" class=\"abstract_t\">19</a>]. In another report of 166 cases and 175 controls who were evaluated for sexually transmitted diseases (STDs), the attributable risk of gonococcal infection for preterm birth was 14 percent [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/16\" class=\"abstract_t\">16</a>]. The association with prematurity appeared to be specific for gonococcal infection and not for other STDs.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">OPHTHALMIA NEONATORUM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The eye is the most frequent site of gonococcal infection in the newborn. As noted above, gonococcal infection is a rare, although serious, cause of ophthalmia neonatorum in developed countries due in large measure to the use of routine prophylaxis. Although also decreasing in frequency in developing countries, it still causes blindness [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/23\" class=\"abstract_t\">23</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Clinical features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infection typically causes a purulent conjunctivitis, with profuse exudate and swelling of the eyelids (<a href=\"image.htm?imageKey=PEDS%2F66751\" class=\"graphic graphic_picture graphicRef66751 \">picture 1</a>). Without treatment, the infection can extend from the superficial epithelial layers into the subconjunctival connective tissue and the cornea, leading to ulceration, scarring, and visual impairment.</p><p>The infection usually becomes manifest two to five days after birth. However, factors including ophthalmic prophylaxis, inoculum size, or variations in virulence may result in a more indolent course and delay in onset.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Newborns who develop conjunctivitis after the first day of age or appear to have severe or persistent chemical conjunctivitis should be evaluated. A Gram stain of the conjunctival exudate should be examined for the presence of typical gram-negative intracellular kidney bean-shaped diplococci. Caution should be used in interpreting the Gram stain results since other nonpathogenic <em>Neisseria</em> species can be mistaken for <em>N. gonorrhoeae</em> [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/1\" class=\"abstract_t\">1</a>]. Culture of the exudate should be performed using selective media (eg, modified Thayer-Martin medium) that inhibit normal flora and nonpathogenic <em>Neisseria </em>organisms. Cultures from other sites (eg, oropharyngeal and rectal swabs) can also be helpful in confirming the diagnosis.</p><p>Newborns with conjunctivitis should be evaluated for <em>C. trachomatis</em>. Coinfection with this organism is common with gonococcal disease. (See <a href=\"topic.htm?path=chlamydia-trachomatis-infections-in-the-newborn\" class=\"medical medical_review\">&quot;Chlamydia trachomatis infections in the newborn&quot;</a>.)</p><p>The infant's mother and her sexual partner(s) should be evaluated and treated for gonococcal infection (see <a href=\"topic.htm?path=treatment-of-uncomplicated-neisseria-gonorrhoeae-infections\" class=\"medical medical_review\">&quot;Treatment of uncomplicated Neisseria gonorrhoeae infections&quot;</a>). She also should be evaluated for other sexually transmitted diseases (STDs) including human immunodeficiency virus infection.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Treatment</span></p><p class=\"headingAnchor\" id=\"H1132742892\"><span class=\"h3\">Infants with ophthalmic disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infants with gonococcal ophthalmic disease should be hospitalized and observed for response to therapy and for disseminated disease. Presumptive treatment should be started after obtaining cultures in infants with organisms seen on Gram stain or in those with negative Gram stain, but who are considered to be at high risk (eg, mother with no prenatal care, history of STDs, or substance abuse).</p><p>Treatment consists of a single dose of <a href=\"topic.htm?path=ceftriaxone-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftriaxone</a> (25 to 50 <span class=\"nowrap\">mg/kg,</span> not to exceed 125 mg, intravenously [IV] or intramuscularly [IM]) [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/2\" class=\"abstract_t\">2</a>]. Where available, a single dose of <a href=\"topic.htm?path=cefotaxime-pediatric-drug-information\" class=\"drug drug_pediatric\">cefotaxime</a> (100 <span class=\"nowrap\">mg/kg,</span> IV or IM) is an alternative option and is preferred for neonates with hyperbilirubinemia and those receiving calcium-containing IV solutions (eg, parenteral nutrition) [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/24\" class=\"abstract_t\">24</a>]. If cefotaxime is unavailable, <a href=\"topic.htm?path=ceftazidime-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftazidime</a> is another alternative [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/25\" class=\"abstract_t\">25</a>].</p><p>Topical antibiotic therapy alone is inadequate and is not necessary when systemic treatment is provided. The eyes should be irrigated frequently with saline until the discharge clears.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Asymptomatic infants of untreated mothers</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Asymptomatic infants whose mothers have untreated gonococcal infection are at high risk for acquiring infection. These infants also should receive systemic treatment with a single dose of <a href=\"topic.htm?path=ceftriaxone-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftriaxone</a> (25 to 50 <span class=\"nowrap\">mg/kg,</span> up to a total dose of 125 mg, administered IV or IM) or <a href=\"topic.htm?path=cefotaxime-pediatric-drug-information\" class=\"drug drug_pediatric\">cefotaxime</a> (if available; 100 <span class=\"nowrap\">mg/kg,</span> administered IV or IM) and should be evaluated for chlamydial infection [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Prevention</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most effective measure to prevent both gonococcal and chlamydial infections is to diagnosis and treat these infections in pregnant women. In addition, prophylactic antibiotic eye therapy reduces the risk of gonococcal conjunctivitis; however, it is not effective in preventing <em>C. trachomatis</em> conjunctivitis.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h3\">Maternal screening</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The Centers for Disease Control and Prevention (CDC) recommends screening for gonorrhea in women who are at increased risk for infection (eg, those with previous gonorrheal infection or other STDs, with new or multiple sex partners, with inconsistent condom use, who engage in commercial sex work and drug use, and who live in communities with a high prevalence of disease) [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/2\" class=\"abstract_t\">2</a>]. A large study in Uganda found that treating pregnant women presumptively for STDs in areas where these infections are prevalent is effective in reducing the incidence of STDs in the newborn; ophthalmia neonatorum was reduced by 37 percent [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/26\" class=\"abstract_t\">26</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h3\">Neonatal prophylaxis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of contracting gonococcal conjunctivitis is markedly reduced by effective prophylaxis [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/27\" class=\"abstract_t\">27</a>]. Prophylaxis can be administered up to one hour after birth to facilitate infant-family attachment. The following are regimens recommended by the American Academy of Pediatrics [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/1\" class=\"abstract_t\">1</a>] and the CDC.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=erythromycin-pediatric-drug-information\" class=\"drug drug_pediatric\">Erythromycin</a> (0.5 percent) ophthalmic ointment</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=tetracycline-pediatric-drug-information\" class=\"drug drug_pediatric\">Tetracycline</a> (1 percent) ophthalmic ointment; tetracycline ophthalmic ointment is not available in the United States.</p><p/><p>Prophylaxis for gonococcal conjunctivitis is discussed separately. (See <a href=\"topic.htm?path=overview-of-the-routine-management-of-the-healthy-newborn-infant#H6\" class=\"medical medical_review\">&quot;Overview of the routine management of the healthy newborn infant&quot;, section on 'Eye care'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">OTHER LOCALIZED INFECTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In addition to conjunctivitis, localized infection of other mucosal surfaces can occur. The pharynx, vagina, urethra, and anus can be affected [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/8\" class=\"abstract_t\">8</a>]. Scalp abscesses may result from infection introduced by a fetal monitoring electrode [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/28\" class=\"abstract_t\">28</a>]. Neonates with a scalp abscess or in whom sepsis is suspected should be treated for disseminated infection. (See <a href=\"#H18\" class=\"local\">'Treatment'</a> below.)</p><p>Diagnostic evaluation consists of cultures from the affected site, blood, and cerebrospinal fluid to make certain that infection has not spread. With the exception of scalp abscess, which is treated in the same manner as disseminated disease, localized infection should be treated with a single dose of <a href=\"topic.htm?path=ceftriaxone-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftriaxone</a> (25 to 50 <span class=\"nowrap\">mg/kg,</span> not to exceed 125 mg, administered IV or IM) or <a href=\"topic.htm?path=cefotaxime-pediatric-drug-information\" class=\"drug drug_pediatric\">cefotaxime</a> (if available; 100 <span class=\"nowrap\">mg/kg,</span> administered IV or IM).</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">DISSEMINATED INFECTION AND SCALP ABSCESS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disseminated disease may present as sepsis, arthritis, or meningitis. Septic arthritis is the most common manifestation of disseminated disease [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/29-31\" class=\"abstract_t\">29-31</a>]. Gonococcal bacteremia <span class=\"nowrap\">and/or</span> meningitis are rare in the newborn, but can be a complication of ophthalmia neonatorum [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/15,32\" class=\"abstract_t\">15,32</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Clinical features</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gonococcal arthritis typically presents at 2 to 21 days of age. The infant may appear only mildly to moderately ill, and the temperature may be normal or slightly elevated [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/31\" class=\"abstract_t\">31</a>]. Multiple joints usually are affected. The infant typically refuses to move the painful, affected limb.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cultures should be obtained of blood and cerebrospinal fluid. Fluid should be aspirated from an affected joint and Gram stain and culture obtained. Specimens obtained from the conjunctiva, vagina, oropharynx, and rectum are useful for identifying the primary site(s) of infection. A positive Gram stain of exudate, CSF, or joint aspirate provides a presumptive basis for initiating treatment [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infants with arthritis, septicemia, <span class=\"nowrap\">and/or</span> abscess should be treated for seven days with <a href=\"topic.htm?path=ceftriaxone-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftriaxone</a> (25 to 50 <span class=\"nowrap\">mg/kg</span> per dose once daily intravenously [IV] or intramuscularly [IM]) for seven days [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/1,2\" class=\"abstract_t\">1,2</a>]. For infants with hyperbilirubinemia and for those receiving calcium-containing IV fluids (eg, parenteral nutrition), <a href=\"topic.htm?path=cefotaxime-pediatric-drug-information\" class=\"drug drug_pediatric\">cefotaxime</a> (25 <span class=\"nowrap\">mg/kg</span> per dose every 12 hours, IV or IM) is preferred, if available [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/1,24\" class=\"abstract_t\">1,24</a>]. If cefotaxime is unavailable, <a href=\"topic.htm?path=ceftazidime-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftazidime</a> is another alternative [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/25\" class=\"abstract_t\">25</a>]. If meningitis is documented, the duration should be extended to 10 to 14 days [<a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/1\" class=\"abstract_t\">1</a>].</p><p>Other classes of antibiotics (eg, macrolides, fluoroquinolones) should <strong>not</strong> be used because of high resistance rates. <em>N. gonorrhoeae</em> drug resistance is discussed in detail separately. (See <a href=\"topic.htm?path=treatment-of-uncomplicated-neisseria-gonorrhoeae-infections#H7889004\" class=\"medical medical_review\">&quot;Treatment of uncomplicated Neisseria gonorrhoeae infections&quot;, section on 'Antibiotic resistance'</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=newborn-conjunctivitis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Newborn conjunctivitis (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H19\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Newborns acquire gonococcal infection during delivery. The perinatal transmission rate is about 30 to 40 percent in women with cervical infection. (See <a href=\"#H4\" class=\"local\">'Perinatal transmission'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the newborn, the eye is the most frequent site of gonococcal infection and is typically characterized by a purulent conjunctivitis with profuse exudate and swelling of the eyelids. Without treatment, the infection can extend from the superficial epithelial layers into the subconjunctival connective tissue and the cornea, leading to ulceration, scarring, and visual impairment. The diagnosis is confirmed by culture of the exudate. (See <a href=\"#H6\" class=\"local\">'Ophthalmia neonatorum'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Empirical antibiotic therapy of a single dose of <a href=\"topic.htm?path=ceftriaxone-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftriaxone</a> (25 to 50 <span class=\"nowrap\">mg/kg,</span> not to exceed 125 mg, intravenously [IV] or intramuscularly [IM]) is administered in any infant with suspected gonococcal ophthalmia neonatorum. Infants with confirmed gonococcal disease should also be evaluated for coinfection with <em>Chlamydia trachomatis</em>. (See <a href=\"#H6\" class=\"local\">'Ophthalmia neonatorum'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The incidence of gonococcal ophthalmia neonatorum has decreased with the use of routine antibiotic prophylaxis and maternal screening for sexually transmitted disease (STD). (See <a href=\"#H11\" class=\"local\">'Prevention'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other localized gonococcal infections include infections of other mucosal surfaces, which are treated with a single IV or IM dose of <a href=\"topic.htm?path=ceftriaxone-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftriaxone</a> (25 to 50 <span class=\"nowrap\">mg/kg,</span> not to exceed 125 mg) or <a href=\"topic.htm?path=cefotaxime-pediatric-drug-information\" class=\"drug drug_pediatric\">cefotaxime</a> (if available, 100 <span class=\"nowrap\">mg/kg)</span>. (See <a href=\"#H14\" class=\"local\">'Other localized infection'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In newborns, systemic gonococcal infection (eg, septic arthritis, sepsis, <span class=\"nowrap\">and/or</span> meningitis) is rare and is usually a complication of localized infection. Infants with arthritis, septicemia, <span class=\"nowrap\">and/or</span> scalp abscess should be treated with <a href=\"topic.htm?path=ceftriaxone-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftriaxone</a> (25 to 50 <span class=\"nowrap\">mg/kg</span> per dose IV or IM once daily) or <a href=\"topic.htm?path=cefotaxime-pediatric-drug-information\" class=\"drug drug_pediatric\">cefotaxime</a> (if available, 25 <span class=\"nowrap\">mg/kg</span> per dose IV or IM every 12 hours) for seven days. Cefotaxime is preferred in infants with hyperbilirubinemia and those receiving calcium-containing IV fluids. If cefotaxime is unavailable, <a href=\"topic.htm?path=ceftazidime-pediatric-drug-information\" class=\"drug drug_pediatric\">ceftazidime</a> is an alternative. In patients with meningitis, the duration of therapy is extended to a minimum of 10 days. (See <a href=\"#H14\" class=\"local\">'Other localized infection'</a> above and <a href=\"#H15\" class=\"local\">'Disseminated infection and scalp abscess'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">American Academy of Pediatrics. Gonococcal infections. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th, Kimberlin DW (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.356.</li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/2\" class=\"nounderline abstract_t\">Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1.</a></li><li class=\"breakAll\">Centers for Disease Control and Prevention (CDC) 2016 sexually transmitted diseases surveillance: STDs in women and infants. Available at: https://www.cdc.gov/std/stats16/womenandinf.htm (Accessed on October 10, 2017).</li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/4\" class=\"nounderline abstract_t\">Desenclos JC, Garrity D, Scaggs M, Wroten JE. Gonococcal infection of the newborn in Florida, 1984-1989. Sex Transm Dis 1992; 19:105.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/5\" class=\"nounderline abstract_t\">Di Bartolomeo S, Mirta DH, Janer M, et al. Incidence of Chlamydia trachomatis and other potential pathogens in neonatal conjunctivitis. Int J Infect Dis 2001; 5:139.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/6\" class=\"nounderline abstract_t\">Nsanze H, Dawodu A, Usmani A, et al. Ophthalmia neonatorum in the United Arab Emirates. Ann Trop Paediatr 1996; 16:27.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/7\" class=\"nounderline abstract_t\">Pandey KK, Bhat BV, Kanungo R, et al. Clinico-bacteriological study of neonatal conjunctivitis. Indian J Pediatr 1990; 57:527.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/8\" class=\"nounderline abstract_t\">Darville T. Gonorrhea. Pediatr Rev 1999; 20:125.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/9\" class=\"nounderline abstract_t\">Ram S, Cullinane M, Blom AM, et al. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med 2001; 193:281.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/10\" class=\"nounderline abstract_t\">Knapp JS, Tam MR, Nowinski RC, et al. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 1984; 150:44.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/11\" class=\"nounderline abstract_t\">Alcorn TM, Cohen MS. Gonococcal pathogenesis: Adaptation and immune evasion in the human host. Curr Opin Infect Dis 1994; 7:310.</a></li><li class=\"breakAll\">Elkins CE, Sparling PF. Immunobiology of Neisseria gonorrhoeae. In: Sexually Transmitted Diseases: Advances in Host Defense Mechanisms, Quinn TC, Gallin J, Fauci AS (Eds), Raven Press, New York 1992. Vol 8, p.113.</li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/13\" class=\"nounderline abstract_t\">Seifert HS. Questions about gonococcal pilus phase- and antigenic variation. Mol Microbiol 1996; 21:433.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/14\" class=\"nounderline abstract_t\">Fiscus SA, Adimora AA, Schoenbach VJ, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA 1996; 275:1483.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/15\" class=\"nounderline abstract_t\">Alexander ER. Gonorrhea in the newborn. Ann N Y Acad Sci 1988; 549:180.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/16\" class=\"nounderline abstract_t\">Elliott B, Brunham RC, Laga M, et al. Maternal gonococcal infection as a preventable risk factor for low birth weight. J Infect Dis 1990; 161:531.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/17\" class=\"nounderline abstract_t\">Amstey MS, Steadman KT. Asymptomatic gonorrhea and pregnancy. J Am Vener Dis Assoc 1976; 3:14.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/18\" class=\"nounderline abstract_t\">Israel KS, Rissing KB, Brooks GF. Neonatal and childhood gonococcal infections. Clin Obstet Gynecol 1975; 18:143.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/19\" class=\"nounderline abstract_t\">Donders GG, Desmyter J, De Wet DH, Van Assche FA. The association of gonorrhoea and syphilis with premature birth and low birthweight. Genitourin Med 1993; 69:98.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/20\" class=\"nounderline abstract_t\">Edwards LE, Barrada MI, Hamann AA, Hakanson EY. Gonorrhea in pregnancy. Am J Obstet Gynecol 1978; 132:637.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/21\" class=\"nounderline abstract_t\">Charles AG, Cohen S, Kass MB, Richman R. Asymptomatic gonorrhea in prenatal patients. Am J Obstet Gynecol 1970; 108:595.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/22\" class=\"nounderline abstract_t\">Handsfield HH, Hodson WA, Holmes KK. Neonatal gonococcal infection. I. Orogastric contamination with Neisseria gonorrhoea. JAMA 1973; 225:697.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/23\" class=\"nounderline abstract_t\">Rahi JS, Sripathi S, Gilbert CE, Foster A. The importance of prenatal factors in childhood blindness in India. Dev Med Child Neurol 1997; 39:449.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/24\" class=\"nounderline abstract_t\">Bradley JS, Wassel RT, Lee L, Nambiar S. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics 2009; 123:e609.</a></li><li class=\"breakAll\">Alternatives to consider during cefotaxime shortage. AAP News. Available at: http://www.aappublications.org/content/early/2015/02/25/aapnews.20150225-1 (Accessed on May 22, 2017).</li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/26\" class=\"nounderline abstract_t\">Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol 2001; 185:1209.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/27\" class=\"nounderline abstract_t\">Laga M, Meheus A, Piot P. Epidemiology and control of gonococcal ophthalmia neonatorum. Bull World Health Organ 1989; 67:471.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/28\" class=\"nounderline abstract_t\">Varady E, Nsanze H, Slattery T. Gonococcal scalp abscess in a neonate delivered by caesarean section. Sex Transm Infect 1998; 74:451.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/29\" class=\"nounderline abstract_t\">Cooperman MB. Gonococcus arthritis in infancy: a clinical study of 44 cases. Am J Dis Child 1927; 33:932.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/30\" class=\"nounderline abstract_t\">Kohen DP. Neonatal gonococcal arthritis: three cases and review of the literature. Pediatrics 1974; 53:436.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/31\" class=\"nounderline abstract_t\">Babl FE, Ram S, Barnett ED, et al. Neonatal gonococcal arthritis after negative prenatal screening and despite conjunctival prophylaxis. Pediatr Infect Dis J 2000; 19:346.</a></li><li><a href=\"https://www.uptodate.com/contents/gonococcal-infection-in-the-newborn/abstract/32\" class=\"nounderline abstract_t\">Erdem G, Schleiss MR. Gonococcal bacteremia in a neonate. Clin Pediatr (Phila) 2000; 39:43.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 4983 Version 23.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H19\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PATHOGENESIS</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">PERINATAL TRANSMISSION</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Association with prematurity</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">OPHTHALMIA NEONATORUM</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">Clinical features</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Diagnosis</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Treatment</a><ul><li><a href=\"#H1132742892\" id=\"outline-link-H1132742892\">- Infants with ophthalmic disease</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Asymptomatic infants of untreated mothers</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">Prevention</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">- Maternal screening</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">- Neonatal prophylaxis</a></li></ul></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">OTHER LOCALIZED INFECTION</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">DISSEMINATED INFECTION AND SCALP ABSCESS</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">Clinical features</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Diagnosis</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">Treatment</a></li></ul></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H12440134\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/4983|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/66751\" class=\"graphic graphic_picture\">- Gonococcal ophthalmia neonatorum</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=chlamydia-trachomatis-infections-in-the-newborn\" class=\"medical medical_review\">Chlamydia trachomatis infections in the newborn</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=congenital-syphilis-evaluation-management-and-prevention\" class=\"medical medical_review\">Congenital syphilis: Evaluation, management, and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-testing-for-hiv-infection-in-infants-and-children-younger-than-18-months\" class=\"medical medical_review\">Diagnostic testing for HIV infection in infants and children younger than 18 months</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-pathogenesis-of-neisseria-gonorrhoeae-infection\" class=\"medical medical_review\">Epidemiology and pathogenesis of Neisseria gonorrhoeae infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-of-chlamydia-trachomatis-infections\" class=\"medical medical_review\">Epidemiology of Chlamydia trachomatis infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-viruses-and-the-newborn-clinical-manifestations-and-treatment\" class=\"medical medical_review\">Hepatitis viruses and the newborn: Clinical manifestations and treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-clinical-features-and-diagnosis\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=neonatal-herpes-simplex-virus-infection-management-and-prevention\" class=\"medical medical_review\">Neonatal herpes simplex virus infection: Management and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-routine-management-of-the-healthy-newborn-infant\" class=\"medical medical_review\">Overview of the routine management of the healthy newborn infant</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=newborn-conjunctivitis-the-basics\" class=\"medical medical_basics\">Patient education: Newborn conjunctivitis (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-uncomplicated-neisseria-gonorrhoeae-infections\" class=\"medical medical_review\">Treatment of uncomplicated Neisseria gonorrhoeae infections</a></li></ul></div></div>","javascript":null}